Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Immediate, Residual, and Cumulative Effects of Fartlek, Hill Circuit, and Roll-On Training in Long-Distance Runners (IRCT-LDR)

25 agosto 2026 aggiornato da: Awoke Tibebu, Debre Markos University

Immediate, Residual, and Cumulative Effects of Fartlek, Hill Circuit, and Roll-On Training Modalities: A Comprehensive Examination of Conditioning in Long-Distance Runners

This randomized controlled trial will compare Fartlek, hill circuit, and roll-on training in well-trained long-distance runners. Twenty-one eligible runners will be randomly assigned to one of three training groups and will complete a 12-week intervention comprising 24 prescribed training sessions. The study will evaluate immediate responses to conditioning, 24-hour recovery responses, and cumulative changes in running performance, aerobic fitness, and training-related responses. Outcomes will include heart rate, blood lactate concentration, rating of perceived exertion, delayed-onset muscle soreness, recovery and wellness indicators, internal training load, 5-km time-trial performance, and VO₂max. The findings will provide evidence regarding the comparative responses to these three conditioning modalities in well-trained long-distance runners.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Long-distance running places substantial physiological and mechanical demands on athletes. Appropriate conditioning is therefore important for developing the capacity to tolerate training stress, recover effectively, and maintain or improve running performance. Different conditioning modalities may impose distinct physiological and mechanical demands, which may result in differences in immediate exercise responses, post-exercise recovery, training load, and longer-term adaptation.

This randomized controlled trial will compare three conditioning modalities. Fartlek training, hill circuit training, and roll-on training in well-trained long-distance runners. Twenty-one eligible runners will be randomly allocated to one of three parallel training groups: the Fartlek Training Group, Hill Circuit Training Group, or Roll-On Training Group. Each group will complete its assigned conditioning modality for 12 weeks, comprising 24 prescribed training sessions.

The study will examine three dimensions of response to conditioning. Immediate responses will include physiological and perceptual responses measured during or immediately after training. Residual responses will focus on recovery-related responses during the 24 hours following conditioning sessions. Cumulative responses will examine changes that develop over repeated exposure to the training intervention, including changes in running performance and aerobic fitness.

Repeated measurements will be collected throughout the intervention to characterize responses to the three conditioning modalities. Measures will include heart rate, blood lactate concentration, rating of perceived exertion, delayed-onset muscle soreness, recovery and wellness indicators, internal training load, 5-km time-trial performance, and VO₂max. Training-load measures will be derived from session rating of perceived exertion and session duration and will be used to characterize the training demands accumulated during the intervention.

The study will compare the response patterns among the three intervention groups to determine whether Fartlek, hill circuit, or roll-on training produces different immediate, residual, and cumulative responses in well-trained long-distance runners. The findings are intended to contribute evidence for the selection and progression of conditioning modalities while considering training stimulus, recovery, and performance-related responses.

Tipo di studio

Interventistico

Iscrizione (Stimato)

21

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

Sì

Descrizione

Inclusion Criteria:

Male long-distance runners aged 18-25 years VO₂max greater than 60 mL/kg/min Weekly training volume of at least 60 km Training experience of at least 4 years Mercier score greater than 600 Currently engaged in regular long-distance running training Willing to participate in the 12-week training intervention Able to complete all required testing and monitoring procedures Provides written informed consent to participate in the study

Exclusion Criteria:

Current musculoskeletal injury that prevents participation in training or testing Known cardiovascular, respiratory, metabolic, or other medical condition that limits strenuous exercise Current illness or condition that prevents participation in the intervention Use of medication or other treatment that may substantially affect exercise performance or physiological responses Failure to meet the required training or eligibility criteria Planned absence that would prevent adequate participation in the intervention Withdrawal of informed consent Any condition identified by the research team that makes continued participation unsafe

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Fartlek Training Group (FTG)
A structured Fartlek running training intervention administered for 12 weeks to trained long-distance runners. The intervention consists of planned variable-intensity running bouts with prescribed duration, repetitions, running intensity, recovery periods, and progressive workload according to the study protocol. Training sessions will be supervised and standardized across participants.
Comportamentale: Fartlek training
A structured variable-intensity running intervention administered for 12 weeks to trained long-distance runners. Each prescribed session includes standardized warm-up and cool-down periods, alternating faster and slower running at prescribed intensities, and prescribed recovery periods. Running duration, intensity, repetitions, recovery intervals, and workload progression are standardized according to the study protocol. Training sessions are supervised, and exercise intensity is monitored using heart rate, rating of perceived exertion, running pace, and prescribed workload.
Sperimentale: Hill Circuit Training Group (HCTG)
Participants assigned to the Hill Circuit Training Group (HCTG) will receive the prescribed Hill Circuit training intervention during the 12-week randomized controlled trial. The intervention consists of structured hill-running and circuit-based training designed for trained long-distance runners. Training intensity, duration, repetitions, recovery periods, and progression will be prescribed according to the study protocol.
Comportamentale: Hill Circuit
A structured hill-running and circuit-based training intervention administered for 12 weeks to trained long-distance runners. Each prescribed session includes standardized warm-up and cool-down periods, repeated uphill running bouts, running-based circuit exercises, and prescribed recovery intervals. Hill gradient, running duration, repetitions, exercise intensity, recovery intervals, and workload progression are standardized according to the study protocol. Exercise intensity is monitored using heart rate, rating of perceived exertion, running pace, and prescribed workload.
Sperimentale: Roll-On Training Group (ROTG)
Participants assigned to the Roll-On Training Group (ROTG) will receive the prescribed Roll-On training intervention during the 12-week randomized controlled trial. The intervention consists of structured progressive running sessions designed for trained long-distance runners. Training intensity, duration, repetitions, recovery periods, and progression will be prescribed according to the study protocol.
Comportamentale: Roll-On
A structured progressive running intervention administered for 12 weeks to trained long-distance runners. Each prescribed session includes standardized warm-up and cool-down periods, controlled running with planned gradual increases and decreases in running speed, and prescribed recovery periods where applicable. Running duration, speed progression, intensity, repetitions, recovery intervals, and workload progression are standardized according to the study protocol. Exercise intensity is monitored using heart rate, rating of perceived exertion, running pace, and prescribed workload.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
5-km Time-Trial Performance
Lasso di tempo: Baseline week 6 and Week 12
Change in 5-km time-trial completion time from baseline to Week 6 and Week 12, comparing the Fartlek Training Group (FTG), Hill Circuit Training Group (HCTG), and Roll-On Training Group (ROTG).
Baseline week 6 and Week 12

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
VO₂max
Lasso di tempo: Baseline, Week 6, and Week 12
Change in maximal oxygen uptake (VO₂max), measured in mL/kg/min, from baseline to Week 6 and Week 12, comparing FTG, HCTG, and ROTG.
Baseline, Week 6, and Week 12
Blood Lactate Concentration
Lasso di tempo: Immediately pre-training and post-training during intervention sessions in Weeks 1-12
Change in blood lactate concentration, measured in mmol/L, immediately following prescribed conditioning sessions to characterize the acute physiological response to Fartlek, Hill Circuit, and Roll-On training.
Immediately pre-training and post-training during intervention sessions in Weeks 1-12
Rating of Perceived Exertion (RPE)
Lasso di tempo: Immediately after each training session during Weeks 1-12
Session rating of perceived exertion will be measured using the OMNI perceived-exertion scale immediately following each conditioning session.
Immediately after each training session during Weeks 1-12
Heart Rate Response
Lasso di tempo: During each training session during Weeks 1-12
Change in average and maximum heart rate during prescribed conditioning sessions to characterize the acute cardiovascular response to Fartlek, Hill Circuit, and Roll-On training.
During each training session during Weeks 1-12
Complete Blood Count (CBC)
Lasso di tempo: Baseline, Week 6, and Week 12
Change in selected hematological parameters, including hemoglobin, hematocrit, red blood cell count parameters.
Baseline, Week 6, and Week 12
5-km Performance Score
Lasso di tempo: Baseline and Week 12
Change in performance score calculated using the applicable World Athletics scoring table based on 5-km time-trial performance from baseline to Week 12, comparing FTG, HCTG, and ROTG.
Baseline and Week 12

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Delayed-Onset Muscle Soreness (DOMS)
Lasso di tempo: Immediately post-training and 24 hours after each conditioning session during Weeks 1-12
Change in self-reported muscle soreness following each prescribed conditioning session to assess post-exercise muscular recovery.
Immediately post-training and 24 hours after each conditioning session during Weeks 1-12
Recovery and Wellness
Lasso di tempo: Before and 24 hours after each conditioning session during Weeks 1-12
Change in recovery and wellness indicators, including sleep duration, sleep quality, fatigue, stress, mood, and overall wellness score, assessed following conditioning sessions.
Before and 24 hours after each conditioning session during Weeks 1-12
Acute Training Load
Lasso di tempo: Weeks 1-12
Weekly acute internal training load calculated from accumulated session training loads, where session training load is calculated as session duration multiplied by session rating of perceived exertion (sRPE).
Weeks 1-12
Chronic Training Load
Lasso di tempo: Weeks 4-12
Chronic internal training load calculated as the rolling 4-week average of weekly training load during the intervention.
Weeks 4-12
Training Monotony
Lasso di tempo: Weeks 1-12
Weekly training monotony calculated as the mean daily training load divided by the standard deviation of daily training load within each training week.
Weeks 1-12
Training Strain
Lasso di tempo: Weeks 1-12
Weekly training strain calculated as weekly training load multiplied by training monotony during the 12-week intervention.
Weeks 1-12
Freshness Index
Lasso di tempo: Weeks 1-12
Weekly freshness index calculated as chronic training load minus acute training load to characterize changes in training readiness during the intervention.
Weeks 1-12
Acute:Chronic Workload Ratio (ACWR)
Lasso di tempo: Weeks 4-12
Weekly acute:chronic workload ratio calculated as acute training load divided by chronic training load during the intervention.
Weeks 4-12

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Debre Markos University

Collaboratori

Bahir Dar University

Investigatori

  • Direttore dello studio: Alemayehu, PHd, University of Gonder
  • Cattedra di studio: Gashaw, PHd, Bahir Dar University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

21 settembre 2026

Completamento primario (Stimato)

24 settembre 2026

Completamento dello studio (Stimato)

26 novembre 2026

Date di iscrizione allo studio

Primo inviato

17 agosto 2026

Primo inviato che soddisfa i criteri di controllo qualità

20 agosto 2026

Primo Inserito (Effettivo)

25 agosto 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

26 agosto 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

25 agosto 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Altri numeri di identificazione dello studio

  • IRERC-19-2025
  • bdu1500226 (Altro identificatore: Bahir Dar University)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

State that de-identified individual participant data and supporting information will be available upon reasonable request, subject to ethical approval and protection of participant confidentiality.

Periodo di condivisione IPD

After publication of the primary results.

Criteri di accesso alla condivisione IPD

Access to individual participant data (IPD) and supporting information will be provided to qualified researchers whose proposed use is scientifically sound and consistent with the informed consent and ethical approvals of the study. Researchers may request access to de-identified IPD, the study protocol, statistical analysis plan (SAP), informed consent form (ICF), clinical study report (CSR), and analytic code, as applicable. Requests will be reviewed by the study investigators and/or the responsible institutional research ethics authority. Approved data will be shared through a secure data-sharing mechanism following execution of an appropriate data-use agreement. Data will not include direct participant identifiers.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • LINFA
  • ICF
  • CODICE_ANALITICO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi